Glycogen Storage Disease Type III clinical trials at University of California Health

• Study to Evaluate Biomarkers and Clinical Manifestations in Individuals With Glycogen Storage Disease Type III (GSD III)

  open to eligible people ages 5-65

  The primary objective of this study is to evaluate potential biomarkers of GSD III.

  at UC Irvine

Last updated: June 30, 2021